Assisting anti-PD-1 antibody treatment with a liposomal system capable of recruiting immune cells.
Sign Up to like & getrecommendations! Published in 2019 at "Nanoscale"
DOI: 10.1039/c9nr01434a
Abstract: Despite the functions of anti-PD-1 antibodies as immune checkpoint regulators, less than 30% of patients exhibit durable therapeutic responses to anti-PD-1 antibodies. Studies have shown that insufficient infiltration of immune cells might limit the outcome… read more here.
Keywords: assisting anti; anti antibody; treatment; liposomal system ... See more keywords